Suchergebnisse - "Kuykendall, Andrew"

PubPharm (102)

1

Incidence of pleural effusion with dasatinib and the effect of switching therapy to a different TKI in patients with chronic phase CML

enthalten in: Annals of hematology | 2024

von Jain, A. | Gesiotto, Q. | Ball, S. | +10

2

Clinical and Therapeutic Intervention of Hypereosinophilia in the Era of Molecular Diagnosis

enthalten in: Cancers | 2024

von Nguyen, L. | Saha, A. | Kuykendall, A. | +1

3

Investigation of Serum Albumin as a Dynamic Treatment-Specific Surrogate for Outcomes in Patients With Myelofibrosis Treated With Ruxolitinib

enthalten in: JCO precision oncology | 2024

von Kuykendall, A. | Ball, S. | Mora, B. | +12

4

Mutations highly specific for secondary AML are associated with poor outcomes in ELN favorable risk NPM1-mutated AML

enthalten in: Blood advances | 2024

von Chan, O. | Al Ali, N. | Tashkandi, H. | +19

5

Triple-Negative Myelofibrosis : Disease Features, Response to Treatment and Outcomes

enthalten in: Clinical lymphoma, myeloma & leukemia | 2024

von Aguirre, L. | Jain, A. | Ball, S. | +10

6

SHP2 inhibition displays efficacy as a monotherapy and in combination with JAK2 inhibition in preclinical models of myeloproliferative neoplasms

enthalten in: American journal of hematology | 2024

von Pandey, G. | Mazzacurati, L. | Rowsell, T. | +10

7

Rusfertide, a Hepcidin Mimetic, for Control of Erythrocytosis in Polycythemia Vera

enthalten in: The New England journal of medicine | 2024

von Kremyanskaya, M. | Kuykendall, A. | Pemmaraju, N. | +32

8

Hypomethylating Agents and Venetoclax for Acute Myeloid Leukemia Relapsed After Hematopoietic Stem Cell Transplant

enthalten in: Clinical lymphoma, myeloma & leukemia | 2024

von Ionescu, F. | David, J. | Ravichandran, A. | +15

9

Patterns of lower risk myelodysplastic syndrome progression : factors predicting progression to high-risk myelodysplastic syndrome and acute myeloid leukemia

enthalten in: Haematologica | 2024

von Jain, A. | Ball, S. | Aguirre, L. | +10

10

Young patients with myelofibrosis have distinct clinicomolecular features, favorable prognosis, and commonly exhibit inflammatory comorbidities

enthalten in: Annals of hematology | 2024

von Horvat, N. | Abdallah, E. | Xie, Z. | +9

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]